So far my research has lead me to know about Contraline, a startup biopharma company working on a removable gel that would block spermatozoïdes on their way into the urethra. It seems promising and they will shortly be begining phase 3 trials on humans. However they are not publicly traded.
Other means on male contraceptives are currently studied, such as a male pill but this one is still a little bit far down the road it seems.
However it is a bit astonishing that there doesn't seem to be a single publicly traded company that is working on that.
Is there anyone who would point me any publicly traded company working on this ?
Leave a Reply